Literature DB >> 12061430

Levels of soluble ICAM-1 in premature and full-term neonates with infection.

Melita Apostolou1, Helen Dimitriou, Joseph Kaleyias, Chrissoula Perdikogianni, Eftichia Stiakaki, Christos Costalos, Maria C Kalmanti.   

Abstract

BACKGROUND: Infection in the neonatal period is an extremely serious condition and diagnosis is difficult. C-reactive protein (CRP) is widely used as a marker of infection; however, its usefulness is limited in the early phase. The role of soluble intracellular adhesion molecule-1 (sICAM-1), an adhesion molecule, has been examined in recent studies as an early marker of neonatal infection with controversial results. AIM: Assessment of sICAM-1 concentrations and correlation with CRP, which is the currently used marker of infection, in order to use sICAM as an early diagnostic tool in neonates suspected for infection
METHODS: Blood samples and blood cultures were obtained from two groups of pre-term and full-term neonates with clinical suspicion of infection prior to the initiation of antibiotics. The sICAM-1 and CRP values were compared with the corresponding noninfected ones (n = 10 each).
RESULTS: The sICAM-1 levels were found increased in the group of both premature and term neonates with infection compared with the corresponding healthy ones (P < 0.0001). Prematurity combined with infection resulted in excessive increase of the levels of sICAM-1 in comparison with full-term infected newborns (p < 0.001). CRP values were normal in all samples except one in both full-term and premature infected neonates on day 1 of clinically suspected infection. Serial detection of CRP values on days 2 and 4 of infection revealed a pattern according to which CRP values in premature neonates continued rising, while in the group of full terms these values, after rising on the second day, lowered on day 4.
CONCLUSIONS: Increased sICAM-1 levels can be detected early in both full-term and premature neonates with sepsis while CRP levels are within normal range at the same time. Assessment of sICAM-1 concentrations may be used as a diagnostic tool in neonates suspected for infection, resulting in earlier initiation of antibiotic therapy and therefore improving their outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061430      PMCID: PMC1781652          DOI: 10.1080/09629350220131944

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

1.  Comparative study of serum soluble VCAM-1 and ICAM-1 levels in the early neonatal period.

Authors:  G Giannaki; K Xyni; D Rizos; I Phocas
Journal:  Acta Paediatr       Date:  1999-12       Impact factor: 2.299

Review 2.  Diagnostic tests for bacterial infection from birth to 90 days--a systematic review.

Authors:  P W Fowlie; B Schmidt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

3.  Soluble intercellular adhesion molecule and C-reactive protein as early markers of infection in newborns.

Authors:  A B Hansen; H Verder; P Staun-Olsen
Journal:  J Perinat Med       Date:  2000       Impact factor: 1.901

4.  Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selectin.

Authors:  R Austgulen; K J Arntzen; P E Haereid; S Aag; H Døllner
Journal:  Acta Paediatr       Date:  1997-03       Impact factor: 2.299

5.  Significance of serial C-reactive protein responses in neonatal infection and other disorders.

Authors:  M Pourcyrous; H S Bada; S B Korones; V Baselski; S P Wong
Journal:  Pediatrics       Date:  1993-09       Impact factor: 7.124

6.  Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis.

Authors:  J C Smulian; V Bhandari; W A Campbell; J F Rodis; A M Vintzileos
Journal:  J Matern Fetal Med       Date:  1997 Sep-Oct

7.  Predictive value of soluble immunological mediators in neonatal infection.

Authors:  J D Edgar; D C Wilson; S A McMillan; A D Crockard; M I Halliday; K R Gardiner; B J Rowlands; H L Halliday; T A McNeill
Journal:  Clin Sci (Lond)       Date:  1994-08       Impact factor: 6.124

8.  Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia.

Authors:  C Berger; J Uehlinger; D Ghelfi; N Blau; S Fanconi
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

9.  Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis.

Authors:  S Aoki; K Imai; A Yachi
Journal:  Scand J Immunol       Date:  1993-11       Impact factor: 3.487

10.  Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants.

Authors:  S Little; T Dean; S Bevin; M Hall; M Ashton; M Church; J Warner; J Shute
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

View more
  4 in total

Review 1.  Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults.

Authors:  Rens Zonneveld; Roberta Martinelli; Nathan I Shapiro; Taco W Kuijpers; Frans B Plötz; Christopher V Carman
Journal:  Crit Care       Date:  2014-02-18       Impact factor: 9.097

2.  Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study.

Authors:  Julie Korol Wright; Kyla Hayford; Vanessa Tran; Gulam Muhammed Al Kibria; Abdullah Baqui; Ali Manajjir; Arif Mahmud; Nazma Begum; Mashuk Siddiquee; Kevin C Kain; Azadeh Farzin
Journal:  BMC Pediatr       Date:  2018-03-23       Impact factor: 2.125

3.  C-reactive protein for diagnosing late-onset infection in newborn infants.

Authors:  Jennifer Valeska Elli Brown; Nicholas Meader; Jemma Cleminson; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

4.  Serum concentrations of endothelial cell adhesion molecules and their shedding enzymes and early onset sepsis in newborns in Suriname.

Authors:  Rens Zonneveld; Rianne M Jongman; Amadu Juliana; Grietje Molema; Matijs van Meurs; Frans B Plötz
Journal:  BMJ Paediatr Open       Date:  2018-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.